Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Study Assessing Long-Term Exposure With Cytisinicline 3 mg TID

NCT06435221 is registered in ClinicalTrials.gov with Achieve Life Sciences as lead sponsor.

NCT NCT06435221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Study Assessing Long-Term Exposure With Cytisinicline 3 mg TID
Lead sponsor
Achieve Life Sciences
Phase
Phase 3
Overall status
Completed
Start date
May 28, 2024
Completion date
October 6, 2025
Enrollment
479 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation, vaping cessation